Dr. R Ananthanarayanan
Managing Director & Chief Executive Officer
Dr. R Ananthanarayanan (Ananth) is the Managing Director & Chief Executive Officer of Strides with effect from January 09, 2020. He has over three decades of top pedigree global pharmaceutical experience across both the technical and commercial functions. Before joining Strides, Ananth was the Global Chief Operating Officer at Cipla Limited, where he was responsible for the company’s generics business in regulated markets and branded generics in emerging markets. He was also driving their API business, biosimilars, complex drug-device combinations, including 505(b)(2) products. He was also the President & CEO of Global APIs, Biologics, & Medis Generics B2B division at Teva Pharmaceutical Industries Ltd in the US, managing multi-billion P&L responsibility. He has also held leadership roles at Dr. Reddy’s Laboratories, Piramal Healthcare (Formerly Nicholas Piramal), Galpharm International, UK (Acquired by Perrigo Group), and Zydus Cadila. Ananth is a Graduate in Pharmaceutical Sciences and earned his Ph.D. in Pharmaceutical Technology from the University of Mumbai, India. He has also been a member of the Board of Advisors at the School of Pharmacy and Health Sciences at Fairleigh Dickinson University, New Jersey.